GlaxoSmithKline | GSK - Net Income



GlaxoSmithKline reported GBP1.44B in Net Income for its fiscal quarter ending in June of 2025.


Net Income Change Date
AbbVie USD 938M 348M Jun/2025
Alcon AG USD 176M 174M Jun/2025
Almirall EUR 26.58M 4.98M Jun/2025
Amgen USD 1.43B 298M Jun/2025
argenx SE USD 245.36M 75.89M Jun/2025
AstraZeneca USD 2.45B 466M Jun/2025
Bayer EUR -199000000 1.5B Jun/2025
Biogen USD 634.8M 394.3M Jun/2025
Bristol-Myers Squibb USD 1.31B 1.15B Jun/2025
Eli Lilly USD 5.66B 2.9B Jun/2025
Fresenius EUR 330M 101M Jun/2025
Fresenius Medical Care EUR 225M 74M Jun/2025
Galapagos EUR -105748000 47.66M Jun/2025
Genmab DKK 336M 141M Jun/2025
Gilead Sciences USD 1.96B 645M Jun/2025
GlaxoSmithKline GBP 1.44B 181M Jun/2025
Glaxosmithkline GBP 1.44B 1.03B Jun/2025
GRIFOLS EUR 117.06M 57.34M Jun/2025
Hikma Pharmaceutical USD 133M 93M Dec/2024
Lonza CHF 307M 22M Dec/2024
Merck EUR 652M 83M Jun/2025
Merck USD 4.43B 652M Jun/2025
Novartis USD 4.02B 418M Jun/2025
Novo Nordisk 26.5B 2.53B Jun/2025
Orion EUR 82.5M 21.3M Jun/2025
Pfizer USD 2.91B 58M Jun/2025
Philips EUR 240M 165M Jun/2025
Recordati EUR 91.08M 33.96M Jun/2025
Regeneron Pharmaceuticals USD 1.39B 582.9M Jun/2025
Roche Holding CHF 1.01B 2.12B Dec/2024
Sanofi EUR 3.94B 2.07B Jun/2025
Smith & Nephew USD 293M 95M Jun/2025
UCB EUR 857M 649M Dec/2024